** Medical device maker Microbot Medical's MBOT.O shares up 50% at $2.08
** MBOT says its experimental endovascular robotic system, Liberty, met main goal in the study
** Endovascular robotic system assists doctors on minimally invasive surgeries inside blood vessels for treating aneurysms, blockages and other vascular issues
** "Mean difference in radiation exposure between operator and control was (-)29.8 µS, resulting in a mean 92% relative reduction in radiation exposure" - MBOT
** Some robotic systems use radiation-based imaging techniques, like X-rays or gamma rays
** Company says no adverse device events were reported during the study
** Up to last close, stock has risen 24.1% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。